What is the global market size of Cartilage Repair Market?

Cartilage Repair Market size was valued at USD 927.63 million in 2021 and is poised to grow from USD 1040.29 million in 2022 to USD 1570.16 million by 2030, growing at a CAGR of 12.13% in the forecast period (2023-2030).

Who are the key vendors in the Global Cartilage Repair Market?

The global cartilage repair market is fragmented, with a prominent market player acquiring a sizable portion. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective. 'DePuy Synthes (a subsidiary of Johnson & Johnson)', 'Zimmer Biomet Holdings Inc.', 'Smith & Nephew plc', 'Vericel Corporation', 'Osiris Therapeutics Inc. (acquired by Smith & Nephew in 2019)', 'Histogenics Corporation', 'Anika Therapeutics Inc.', 'Arthrex Inc.', 'B. Braun Melsungen AG', 'Stryker Corporation', 'CONMED Corporation', 'Orthocell Limited', 'RTI Surgical Holdings Inc.', 'MEDIPOST Co. Ltd.', 'CellGenix GmbH', 'Tissue Regenix Group plc', 'CollPlant Biotechnologies Ltd.', 'ISTO Technologies Inc.', 'MTF Biologics', 'CartiHeal Ltd'

What is the key driver of Global Cartilage Repair Market?

Osteoarthritis has become increasingly common in recent years throughout the world. According to a University of North Carolina study, approximately 1 million knee and hip replacement procedures are performed in the United States each year. The annual cost of osteoarthritis in the United States is $136.8 billion. According to the Arthritis Foundation, degenerative joint diseases such as osteoarthritis will affect more than 130 million people worldwide by 2050. Two of the most common treatments for osteoarthritis are autologous chondrocyte implantation and Scaffolds implants. As a result, as the prevalence of osteoarthritis rises, so will demand for cartilage repair and regeneration products.

What is the key market trend for Global Cartilage Repair Market?

The number of companies focusing on the development of cartilage regeneration products has increased significantly in recent years as a result of rising government investments in regenerative medicine for cartilage regeneration research. As a result of these factors, the number of clinical trials and the development of new cartilage regeneration technologies has increased. Major market players are investing heavily in R&D, resulting in a robust pipeline of products based on various approaches to cartilage repair.

Which region accounted for the largest share in Cartilage Repair Market?

Based on region global cartilage repair market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa. The Asia Pacific region is expected to grow at a faster rate. North America accounted for the largest share of the cartilage repair and regeneration market, owing to the high prevalence of osteoarthritis, the growing prevalence of sports injuries, and increased research funding in the United States and Canada. In addition, increased physician and patient awareness of innovative treatment techniques and technologies, as well as significant government investments in Cartilage Repair/Regeneration technologies and therapies, are all contributing to the market's growth in North America. Over the projection period, the Asia Pacific region is expected to grow at a faster rate than other regions. Furthermore, the increased prevalence of osteoporosis in Australia and New Zealand is leading to an increase in cartilage injury, which is expected to accelerate vertical growth. South American, Middle Eastern, and African (MEA) markets have been gradually expanding in recent years. Because of the large population suffering from chronic joint and bone problems, these markets have untapped potential.

Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality(Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds), By Application(Knee, Hip, Ankle and Foot, and Other Application Sites), By Application site(Hyaline Cartilage, Fibrocartilage), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35D2072 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 121 | Figures: 77

Cartilage Repair Market News

Medtronic Plc announced in 2022 that it had fully finalized its acquisition of Vapotherm, a respiratory care company that specializes in state-of-the-art ventilation for patients. The acquisition is anticipated to add Medtronic's portfolio of the products offered in the market for the respiratory class, which would feature cartilage repair solutions.
It was in 2021 when Zimmer Biomet launched JuggerStitchTM meniscal repair tool. In essence, the product provides an easier and more convenient meniscal repair option for orthopedic surgeons. The target of this launch is further to improve the market share of Zimmer Biomet regarding cartilage repair.
Sanofi S.A. reportedly said that it acquired the clinical-stage biopharmaceutical business Kymab in 2021. This development is expected to boost Sanofi's research and development business activities within the cartilage repair industry.

Cartilage Repair Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cartilage Repair Market size was valued at around USD 1 billion in 2022 and is expected to rise from USD 1.25 billion in 2023 to reach a value of USD 4.38 billion by 2031, at a CAGR of 17% over the forecast period (2024–2031).

The cartilage repair market is highly competitive and has matured firms as well as new biotech firms. The smaller businesses have been focusing on advanced regenerative medicines, such as tissue engineering and stem cell-based therapies. Growth strategies through strategic alliances, mergers, and ongoing research and development form the majority dynamics for the market. 'DePuy Synthes (Johnson & Johnson) ', 'Zimmer Biomet Holdings Inc. ', 'Smith & Nephew plc ', 'Vericel Corporation ', 'Osiris Therapeutics Inc. ', 'Histogenics Corporation ', 'Anika Therapeutics Inc ', 'Arthrex Inc. ', 'B. Braun Melsungen AG ', 'Stryker Corporation ', 'CONMED Corporation ', 'Orthocell Limited ', 'RTI Surgical Holdings Inc. ', 'MEDIPOST Co. Ltd. ', 'CellGenix GmbH ', 'Tissue Regenix Group plc ', 'CollPlant Biotechnologies Ltd. ', 'ISTO Technologies Inc. ', 'MTF Biologics ', 'CartiHeal Ltd.'

The most common patients requiring knee cartilage repair surgery are young people who have suffered injuries in the knee joint, such as meniscal or ligament tears. Damaged cartilage is repaired using methods that include cell-based cartilage resurfacing and autologous chondrocyte implantation to hasten the formation of new cartilage in joints. It delays and prevents the occurrence of arthritis, which also greatly reduces joint pain and increases joint flexibility through repairing and replacing the cartilage.

Minimally Invasive Techniques: More and more, patients seek therapies that allow rapid recovery, less morbidity, and less pain after surgery. The success of restoring cartilage effectively with fewer incisions and rapid recovery is what appeals to procedures such as arthroscopy, biologic injections (PRP, stem cells), and microfracture surgery. Those techniques will eventually supplant more invasive and traditional operations as they continue to evolve.

In 2023, North America was established as the market leader, commanding a share of over 45%. If people choose a healthy lifestyle, the forecast till at least the end of the review period is for the region to maintain its leading position. The urge for and appeal of cartilage repair in the United States and Canada is largely driven by a target audience and shifts in lifestyles, combined with the ever-increasing rate of musculoskeletal disorders. Further, the incidence of osteoporosis in the UK, Germany, and France is increasing significantly, and about 500,000 people require hospital care each year due to fractures at standing height or below caused by osteoporosis. It is expected to affect the Europe market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cartilage Repair Market News

Cartilage Repair Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cartilage Repair Market?

Who are the key vendors in the Cartilage Repair Market?

What is the key driver of Cartilage Repair Market?

What is the key market trend for Cartilage Repair Market?

Which region accounted for the largest share in Cartilage Repair Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300